US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Applied DNA Sciences Inc (APDN)
Applied DNA Sciences Inc (APDN) ニュース

APDN

Applied DNA Sciences (APDN)

Applied DNA Sciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APDN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2024/05/15	10 : 50	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:APDN	Applied DNA Sciences Inc
2024/03/05	07 : 18	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:APDN	Applied DNA Sciences Inc
2024/02/13	06 : 25	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:APDN	Applied DNA Sciences Inc
2024/02/13	06 : 09	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:APDN	Applied DNA Sciences Inc
2024/02/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2024/02/09	06 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APDN	Applied DNA Sciences Inc
2024/02/02	06 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:APDN	Applied DNA Sciences Inc
2024/01/27	06 : 24	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:APDN	Applied DNA Sciences Inc
2024/01/11	07 : 16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:APDN	Applied DNA Sciences Inc
2024/01/08	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2024/01/06	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/12/08	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/12/08	06 : 01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:APDN	Applied DNA Sciences Inc
2023/12/07	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/11/08	07 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/11/08	07 : 02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:APDN	Applied DNA Sciences Inc
2023/09/21	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/08/11	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/08/11	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APDN	Applied DNA Sciences Inc
2023/08/02	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/07/14	06 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APDN	Applied DNA Sciences Inc
2023/06/07	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:APDN	Applied DNA Sciences Inc
2023/05/12	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APDN	Applied DNA Sciences Inc
2023/05/06	05 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APDN	Applied DNA Sciences Inc
2023/05/04	04 : 00	Business Wire	Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023	NASDAQ:APDN	Applied DNA Sciences Inc
2023/04/08	01 : 00	Business Wire	Applied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal Regulation	NASDAQ:APDN	Applied DNA Sciences Inc
2023/03/29	22 : 00	Business Wire	Applied DNA Achieves Milestone for Large-Scale linearDNA™ Production, Delivers Largest Single Shipment by Volume to Date	NASDAQ:APDN	Applied DNA Sciences Inc
2023/03/28	19 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APDN	Applied DNA Sciences Inc
2023/03/22	22 : 35	Business Wire	Applied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) Assay	NASDAQ:APDN	Applied DNA Sciences Inc

Showing the most relevant articles for your search:NASDAQ:APDN

1 2 3 4 5 6 7 8 9 10 次へ >>

American Express

Health Care Select Sector

Gold vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約